2 purchases reported after at least 12 months of silence — most recent on 19 Sept 2022.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cardiff Oncology, Inc. | 158,681 | reported | 26 Jun 2025 | tx 11+301,327−28,858 |
| CombiMatrix Corp | 0 | reported | 14 Nov 2017 | tx 6+22,320−8,627 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Jun 2025 | GRANT_AWARD | Cardiff Oncology, Inc. | 40,565 | 0.00 USD | deriv |
| 27 Jun 2024 | GRANT_AWARD | Cardiff Oncology, Inc. | 29,700 | 0.00 USD | deriv |
| 15 Jun 2023 | GRANT_AWARD | Cardiff Oncology, Inc. | 27,700 | 0.00 USD | deriv |
| 19 Sept 2022 | PURCHASE |
| Cardiff Oncology, Inc. |
| 15,000 |
| 1.64 USD |
first after silence |
| 05 Jul 2022 | EXERCISE | Cardiff Oncology, Inc. | 28,858 | 2.60 USD |
| 05 Jul 2022 | EXERCISE | Cardiff Oncology, Inc. | 28,858 | 2.60 USD | deriv |
| 09 Mar 2022 | GRANT_AWARD | Cardiff Oncology, Inc. | 26,800 | 0.00 USD | deriv |
| 10 Jun 2021 | GRANT_AWARD | Cardiff Oncology, Inc. | 22,000 | 0.00 USD | deriv |
| 17 Jun 2020 | GRANT_AWARD | Cardiff Oncology, Inc. | 28,858 | 0.00 USD | deriv |
| 14 May 2020 | PURCHASE | Cardiff Oncology, Inc. | 69,930 | 1.43 USD | first after silence |
| 16 Apr 2020 | GRANT_AWARD | Cardiff Oncology, Inc. | 11,916 | 0.00 USD | deriv |
| 14 Nov 2017 | TENDER | CombiMatrix Corp | 7,792 | — |
| 14 Nov 2017 | OTHER | CombiMatrix Corp | 835 | — |
| 09 May 2016 | PURCHASE | CombiMatrix Corp | 901 | 2.94 USD |
| 10 May 2016 | PURCHASE | CombiMatrix Corp | 6,891 | 3.18 USD |
| 12 Mar 2015 | GRANT_AWARD | CombiMatrix Corp | 12,528 | 0.00 USD |
| 12 Mar 2015 | GRANT_AWARD | CombiMatrix Corp | 2,000 | 0.00 USD | deriv |